113 related articles for article (PubMed ID: 8573122)
1. Dexamethasone inhibits insulin binding to insulin-degrading enzyme and cytosolic insulin-binding protein p82.
Harada S; Smith RM; Hu DQ; Jarett L
Biochem Biophys Res Commun; 1996 Jan; 218(1):154-8. PubMed ID: 8573122
[TBL] [Abstract][Full Text] [Related]
2. The expression of and insulin binding to cellular thyroid hormone binding protein, but not insulin degrading enzyme, is increased during 3T3-L1 adipocytes differentiation.
Lee YH; Harada S; Smith RM; Friedman R; Jarett L
Biochem Biophys Res Commun; 1996 May; 222(3):839-43. PubMed ID: 8651932
[TBL] [Abstract][Full Text] [Related]
3. Demonstration of specific insulin binding to cytosolic proteins in H35 hepatoma cells, rat liver and skeletal muscle.
Harada S; Smith RM; Smith JA; Shah N; Jarett L
Biochem J; 1995 Feb; 306 ( Pt 1)(Pt 1):21-8. PubMed ID: 7864812
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of nuclear translocation of insulin.
Harada S; Smith RM; Jarett L
Cell Biochem Biophys; 1999; 31(3):307-19. PubMed ID: 10736753
[TBL] [Abstract][Full Text] [Related]
5. Insulin acts intracellularly on proteasomes through insulin-degrading enzyme.
Duckworth WC; Bennett RG; Hamel FG
Biochem Biophys Res Commun; 1998 Mar; 244(2):390-4. PubMed ID: 9514933
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of insulin-degrading enzyme increases translocation of insulin to the nucleus in H35 rat hepatoma cells: evidence of a cytosolic pathway.
Harada S; Smith RM; Smith JA; Jarett L
Endocrinology; 1993 Jun; 132(6):2293-8. PubMed ID: 8504733
[TBL] [Abstract][Full Text] [Related]
7. Insulin-degrading enzyme hydrolyzes ATP.
Del Carmen Camberos M; Cresto JC
Exp Biol Med (Maywood); 2007 Feb; 232(2):281-92. PubMed ID: 17259336
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide inhibits insulin-degrading enzyme activity and function through S-nitrosylation.
Cordes CM; Bennett RG; Siford GL; Hamel FG
Biochem Pharmacol; 2009 Mar; 77(6):1064-73. PubMed ID: 19154729
[TBL] [Abstract][Full Text] [Related]
9. Alternative splicing of human insulin-degrading enzyme yields a novel isoform with a decreased ability to degrade insulin and amyloid beta-protein.
Farris W; Leissring MA; Hemming ML; Chang AY; Selkoe DJ
Biochemistry; 2005 May; 44(17):6513-25. PubMed ID: 15850385
[TBL] [Abstract][Full Text] [Related]
10. Insulin-degrading enzyme.
Authier F; Posner BI; Bergeron JJ
Clin Invest Med; 1996 Jun; 19(3):149-60. PubMed ID: 8724818
[TBL] [Abstract][Full Text] [Related]
11. Regulation of protein degradation by insulin-degrading enzyme: analysis by small interfering RNA-mediated gene silencing.
Fawcett J; Permana PA; Levy JL; Duckworth WC
Arch Biochem Biophys; 2007 Dec; 468(1):128-33. PubMed ID: 17964527
[TBL] [Abstract][Full Text] [Related]
12. Identification and isolation of a cytosolic proteolytic complex containing insulin degrading enzyme and the multicatalytic proteinase.
Bennett RG; Hamel FG; Duckworth WC
Biochem Biophys Res Commun; 1994 Jul; 202(2):1047-53. PubMed ID: 8048917
[TBL] [Abstract][Full Text] [Related]
13. Delineation of the insulin-responsive sequence in the rat cytosolic aspartate aminotransferase gene: binding sites for hepatocyte nuclear factor-3 and nuclear factor I.
Beurton F; Bandyopadhyay U; Dieumegard B; Barouki R; Aggerbeck M
Biochem J; 1999 Nov; 343 Pt 3(Pt 3):687-95. PubMed ID: 10527950
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid receptor-independent transcriptional induction of cytochrome P450 3A1 by metyrapone and its potentiation by glucocorticoid.
Wright MC; Wang XJ; Pimenta M; Ribeiro V; Paine AJ; Lechner MC
Mol Pharmacol; 1996 Oct; 50(4):856-63. PubMed ID: 8863830
[TBL] [Abstract][Full Text] [Related]
15. [Relationship between insulin-degrading enzyme activity and insulin sensitivity in cell model of insulin-resistance].
Li CZ; Zhang SH; Shu CD; Ren W
Di Yi Jun Yi Da Xue Xue Bao; 2002 Feb; 22(2):151-4. PubMed ID: 12390813
[TBL] [Abstract][Full Text] [Related]
16. Effect of nelfinavir on insulin metabolism, proteasome activity and protein degradation in HepG2 cells.
Hamel FG; Fawcett J; Tsui BT; Bennett RG; Duckworth WC
Diabetes Obes Metab; 2006 Nov; 8(6):661-8. PubMed ID: 17026490
[TBL] [Abstract][Full Text] [Related]
17. Time dependent effects of dexamethasone on serum insulin level and insulin receptors in rat liver and erythrocytes.
Korićanac G; Isenović E; Stojanović-Susulić V; Misković D; Zakula Z; Ribarac-Stepić N
Gen Physiol Biophys; 2006 Mar; 25(1):11-24. PubMed ID: 16714772
[TBL] [Abstract][Full Text] [Related]
18. PPARgamma transcriptionally regulates the expression of insulin-degrading enzyme in primary neurons.
Du J; Zhang L; Liu S; Zhang C; Huang X; Li J; Zhao N; Wang Z
Biochem Biophys Res Commun; 2009 Jun; 383(4):485-90. PubMed ID: 19383491
[TBL] [Abstract][Full Text] [Related]
19. Functional human insulin-degrading enzyme can be expressed in bacteria.
Chesneau V; Rosner MR
Protein Expr Purif; 2000 Jun; 19(1):91-8. PubMed ID: 10833395
[TBL] [Abstract][Full Text] [Related]
20. Hyperinsulinemia caused by dexamethasone treatment is associated with reduced insulin clearance and lower hepatic activity of insulin-degrading enzyme.
Protzek AO; Rezende LF; Costa-Júnior JM; Ferreira SM; Cappelli AP; de Paula FM; de Souza JC; Kurauti MA; Carneiro EM; Rafacho A; Boschero AC
J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt A):1-8. PubMed ID: 26386462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
